DK93388A - Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater - Google Patents

Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater

Info

Publication number
DK93388A
DK93388A DK093388A DK93388A DK93388A DK 93388 A DK93388 A DK 93388A DK 093388 A DK093388 A DK 093388A DK 93388 A DK93388 A DK 93388A DK 93388 A DK93388 A DK 93388A
Authority
DK
Denmark
Prior art keywords
virus
variables
dna
special
preparation
Prior art date
Application number
DK093388A
Other languages
English (en)
Other versions
DK93388D0 (da
DK175819B1 (da
Inventor
Marc Alizon
Pierre Sonigo
Simon Wain-Hobson
Luc Montagnier
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of DK93388D0 publication Critical patent/DK93388D0/da
Publication of DK93388A publication Critical patent/DK93388A/da
Priority to DK200401579A priority Critical patent/DK176153B1/da
Application granted granted Critical
Publication of DK175819B1 publication Critical patent/DK175819B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198800933A 1986-06-23 1988-02-23 LAV-virusvarianter, DNA- og proteinkomponenter deraf og anvendelser deraf, især til diagnostiske formål og til fremstillingen af immunogene præparater DK175819B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200401579A DK176153B1 (da) 1986-06-23 2004-10-15 Protein- eller glycoproteinfragment

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP86401380 1986-06-23
EP86401380 1986-06-23
EP8700326 1987-06-22
PCT/EP1987/000326 WO1987007906A1 (en) 1986-06-23 1987-06-22 Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparartion of immunogenic compositions

Publications (3)

Publication Number Publication Date
DK93388D0 DK93388D0 (da) 1988-02-23
DK93388A true DK93388A (da) 1988-02-23
DK175819B1 DK175819B1 (da) 2005-03-14

Family

ID=8196317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198800933A DK175819B1 (da) 1986-06-23 1988-02-23 LAV-virusvarianter, DNA- og proteinkomponenter deraf og anvendelser deraf, især til diagnostiske formål og til fremstillingen af immunogene præparater

Country Status (10)

Country Link
US (5) US5030714A (da)
EP (1) EP0253701B1 (da)
JP (1) JPS63503513A (da)
AU (1) AU621031B2 (da)
DE (1) DE3783282T2 (da)
DK (1) DK175819B1 (da)
ES (1) ES2052591T3 (da)
GR (1) GR3007493T3 (da)
PT (1) PT85148B (da)
WO (1) WO1987007906A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
US5824482A (en) 1986-06-23 1998-10-20 Institut Pasteur Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
US5034511A (en) * 1987-04-13 1991-07-23 Institut Pasteur Variant of LAV viruses
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna
US5043262A (en) * 1988-05-12 1991-08-27 Dana Farber Cancer Institute Protein, sequences containing the VPU gene therefore, vectors, methods of preparation and use
EP0657532B1 (en) * 1988-06-09 2003-12-17 N.V. Innogenetics S.A. HIV-3 retrovirus strains and their use
FR2640877A1 (da) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
US5278042A (en) * 1989-02-06 1994-01-11 The United States Of America As Represented By The Department Of Health & Human Services Method for detecting inhibitors of tat protein
FR2644176B1 (fr) * 1989-03-07 1993-10-08 Franceville Ctre Internal Recher Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations
FR2646606B1 (fr) * 1989-05-03 1994-06-17 Inst Nat Sante Rech Med Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
EP0682951B1 (en) * 1989-05-31 1997-12-17 Institut Pasteur Immunogenic compositions comprising a purified antigen constituted by the envelope glycoprotein of the HIV-2 EHO retrovirus
FR2647810B1 (fr) * 1989-06-02 1994-07-22 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
DE69033311T2 (de) * 1989-06-02 2000-02-17 Institut National De La Sante Et De La Recherche Medicale I.N.S.E.R.M., Paris Nukleotid-Sequenzen des Genoms von Retroviren vom Typ HIV-1, HIV-2 und SIV, ihre Verwendungen zur Amplifikation dieser Genome und in-vitro-Diagnose dieser viralen Infektionen
US7022814B1 (en) 1992-01-21 2006-04-04 Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
FR2647809B1 (fr) * 1989-06-02 1991-09-20 Pasteur Institut Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
ATE329054T1 (de) 1991-12-23 2006-06-15 Chiron Corp Sätze von hiv sonden für solution sandwich hybridationsverfahren
ATE174382T1 (de) * 1992-10-06 1998-12-15 Dade Behring Marburg Gmbh Retrovirus aus der hiv-gruppe und dessen verwendung
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
JP4278174B2 (ja) 1994-10-20 2009-06-10 アンスティテュ・パストゥール Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
US5891994A (en) * 1997-07-11 1999-04-06 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
DE19850186A1 (de) * 1998-10-30 2000-05-25 Roche Diagnostics Gmbh Neue Primer und Sonden zum Nachweis von HIV
DE19908766C2 (de) * 1999-02-19 2001-02-15 Ulrich Schubert Verwendung synthetischer Vpr-Peptide des Humanen Immundefizienzvirus Typ 1 (HIV-1) zur Entwicklung von therapeutischen und diagnostischen Reagenzien
US6399067B1 (en) * 2000-04-28 2002-06-04 Thymon L.L.C. Methods and compositions for impairing multiplication of HIV-1
AU7104200A (en) 2000-09-01 2002-03-22 Gen Probe Inc Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
US20040191905A1 (en) * 2002-11-22 2004-09-30 University Of Massachusetts Modulation of HIV replication by RNA interference
TW200613554A (en) 2004-06-17 2006-05-01 Wyeth Corp Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
WO2006088740A2 (en) 2005-02-15 2006-08-24 Thymon, L.L.C. Methods and compositions for impairing multiplication of hiv-1
US8405379B1 (en) 2008-09-18 2013-03-26 Luc Montagnier System and method for the analysis of DNA sequences in biological fluids
WO2013111800A1 (ja) * 2012-01-25 2013-08-01 独立行政法人科学技術振興機構 Ｈｉｖ検出用オリゴヌクレオチド、ｈｉｖ検出キット、及びｈｉｖ検出方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
GB8324800D0 (en) 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4784941A (en) 1985-04-08 1988-11-15 Genetic Systems Corporation Expression and diagnostic use of pENV-3 encoded peptides which are immunologically reactive with antibodies to LAV
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
WO1987003908A1 (en) * 1985-12-24 1987-07-02 United States Of America, Represented By The Unite Plasmid and phage clones of human t-cell lymphotropic virus type iii
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US5034511A (en) * 1987-04-13 1991-07-23 Institut Pasteur Variant of LAV viruses
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
AU678225B2 (en) * 1993-03-11 1997-05-22 University Of Southern California Therapeutic strategies for immunoinfective cluster virus infections

Also Published As

Publication number Publication date
US7767800B2 (en) 2010-08-03
EP0253701B1 (en) 1992-12-30
AU7546887A (en) 1988-01-12
ES2052591T3 (es) 1994-07-16
AU621031B2 (en) 1992-03-05
PT85148A (en) 1987-07-01
DK93388D0 (da) 1988-02-23
US20030224352A1 (en) 2003-12-04
PT85148B (pt) 1990-03-30
DE3783282D1 (de) 1993-02-11
DE3783282T2 (de) 1993-05-27
US20020177128A1 (en) 2002-11-28
EP0253701A1 (en) 1988-01-20
JPS63503513A (ja) 1988-12-22
GR3007493T3 (da) 1993-07-30
US5773602A (en) 1998-06-30
US6426073B1 (en) 2002-07-30
WO1987007906A1 (en) 1987-12-30
DK175819B1 (da) 2005-03-14
US5030714A (en) 1991-07-09

Similar Documents

Publication Publication Date Title
DK93388A (da) Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater
DE3485267D1 (de) Herstellung von streptokokken-m-protein-immunogenen und molekularen sonden.
NO872966D0 (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
DK170287A (da) Fremgangsmaade til fremstilling af findelte, pulverformede karotinoidpraeparater
DK246587A (da) 1-aralkylpyrazoler, fremgangsmaader til deres fremstilling og anvendelse til bekaempelse af skadelige organismer
NO900577L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO873993L (no) Fremgangsmaate for fremstilling av fluorid- og calsiumpreparat med langvarig frigjoerelse.
NO165683C (no) Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse.
DK41590A (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK531387A (da) 3-propenylcephemderivater, mellemprodukter til anvendelse ved fremstillingen heraf og praeparater indeholdende foerstnaevnte forbindelser.
DK229387A (da) Retinoesyreestere, deres fremstilling og farmaceutiske og kosmetiske praeparater deraf
DK342187D0 (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK203087A (da) Fremgangsmaade til fremstilling af fusionsproteiner og anvendelse af det derved fremstillede fusionsprotein som vaccine
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
NO873197D0 (no) Bedoevelsespreparat og fremgangsmaate for anvendelse av dette.
NO830966L (no) Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse
NO871634L (no) Plantevernmidler og fremgangsmaate for deres fremstilling.
DK157187D0 (da) Acyloxyhiophencarboxamider, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK693287A (da) Fremgangsmaade til fremstilling af lipophile aminosyrederivater, samt herved opnaaede aminosyrederivater og anvendelsen heraf
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK343988D0 (da) Praeparater med kontrolleret afgivelseshastighed af nulte orden, og fremgangsmaade til fremstilling af saasanne praeparater
DK94087D0 (da) Oprenset human angiogenfaktor, fremgangsmaade til dens fremstilling, og farmaceutiske praeparater

Legal Events

Date Code Title Description
PUP Patent expired